title: In patients hospitalised with acute heart failure, nesiritide, compared with placebo, is not associated with improvements in dyspnoea or 30-day rehospitalisation or mortality.
authors.affiliation: Clinic for Cardiovascular Surgery, University Hospital, Zurich, Switzerland. sacha.salzberg@gmail.com
authors.forename: Sacha P
authors.initials: SP
authors.lastname: Salzberg